Sectors
CAPR
Capricor Therapeutics, Inc.
9.91
1 x 8.75
2 x 11.68
bid
ask
+
0.32
3.34%
2 @ 07:59 PM
9.91 +0.00 (0.01%)
| Ytd | -65.66% | |
| 1y | 57.80% |
9.06
day range
10.23
2.96
52 week range
40.37
| Open | 9.41 | Prev Close | 9.59 | Low | 9.06 | High | 10.23 | Mkt Cap | 576.16M |
| Vol | 4.56M | Avg Vol | 5.90M | EPS | -2.45 | P/E | N/A | Forward P/E | -35.03 |
| Beta | 0.42 | Short Ratio | 13.95 | Inst. Own | 59.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 14.56 | 200-d Avg | 23.27 | 1yr Est | 53.60 |
| Income Statement | |||
| Operating Expenses | 42.95M | ||
| Research and Development Expense | 28.87M | ||
| Selling, General and Administrative Expense | 14.08M | ||
| Operating Income | -42.95M | ||
| Income Tax Expense | 1.60K | ||
| Net Income | -40.73M | ||
| Net Income Common Stock | -40.73M | ||
| Net Income Common Stock (USD) | -40.73M | ||
| Consolidated Income | -40.73M | ||
| Earnings per Basic Share | -0.70 | ||
| Earnings per Basic Share (USD) | -0.70 | ||
| Earnings per Diluted Share | -0.70 | ||
| Earning Before Interest & Taxes (EBIT) | -40.73M | ||
| Earning Before Interest & Taxes (USD) | -40.73M | ||
| Weighted Average Shares | 57.93M | ||
| Weighted Average Shares Diluted | 57.93M | ||
| Balance Sheet | |||
| Cash and Equivalents | 20.94M | ||
| Cash and Equivalents (USD) | 20.94M | ||
| Investments | 217.00M | ||
| Investments Current | 217.00M | ||
| Current Assets | 242.13M | ||
| Property, Plant & Equipment Net | 124.96M | ||
| Total Assets | 368.74M | ||
| Debt Current | 1.49M | ||
| Total Debt | 91.05M | ||
| Current Liabilities | 32.96M | ||
| Debt Non-Current | 89.56M | ||
| Total Liabilities | 122.52M | ||
| Accumulated Retained Earnings (Deficit) | -379.55M | ||
| Accumulated Other Comprehensive Income | -163.54K | ||
| Shareholders Equity | 246.22M | ||
| Shareholders Equity (USD) | 246.22M | ||
| Assets Non-Current | 126.61M | ||
| Total Debt (USD) | 91.05M | ||
| Deferred Revenue | 12.00M | ||
| Liabilities Non-Current | 89.56M | ||
| Trade and Non-Trade Payables | 3.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 561.85K | ||
| Net Cash Flow from Financing | -4.24M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -84.49M | ||
| Capital Expenditure | -5.81M | ||
| Issuance (Purchase) of Equity Shares | 2.10M | ||
| Net Cash Flow from Investing | -48.76M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -42.95M | ||
| Net Cash Flow from Operations | -31.49M | ||
| Share Based Compensation | 6.06M | ||